Can a tablet game sharpen aging minds during breast cancer treatment?
NCT ID NCT04261153
First seen Jul 02, 2026 · Last updated Jul 02, 2026
Summary
This study explores whether a tablet-based cognitive stimulation program called HAPPYNeuron® is practical for breast cancer patients aged 70 and older. Cancer treatments, especially chemotherapy, can cause memory and thinking problems, and older patients may be at higher risk. The study will have participants complete three 20-minute sessions on a tablet to see if they can and will use the software, aiming to find a way to help reduce cognitive side effects and improve quality of life.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
HAPPYNeuron® cognitive stimulation software
What this could lead to
If successful, this could point toward a practical, non-drug way to help older breast cancer patients maintain memory and thinking skills during cancer treatment.
What could go wrong
This is a small feasibility study, so it cannot prove the software improves cognition. Older patients may find tablet use difficult, and the program may not be widely adopted.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BREAST CANCER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- NIR Device for Breast Flap Perfusion Study (NCT07680296)
- Long-Term Heart Effects of Anthracycline in Brea NCT07680855
- Trastuzumab + RAD001 for HER2+ Breast Cancer NCT00317720
- AMPLIFI: Web-Based Lifestyle Program for Cancer NCT04000880
- TIBEC Trial: Tislelizumab Combo for Advanced Tum NCT07681297
- Cognitive difficulties after breast cancer: feas NCT04213365
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Centre François Baclesse
Caen, 14076, France
-
Centre Henri Becquerel
Rouen, France